000			04392cam a2200385Mi 4500
001			94941
003			ES-MaUEC
005			20230102112639.0
006			m o d
007			cr |n|||||||||
008			161130s2017 nyu o 001 0 eng d
020			_a1493966790 _q(electronic bk.)
020			_a9781493966790 _q(electronic bk.)
020			_z1493966774
020			_z9781493966776
035			_a(OCoLC)964531069 _z(OCoLC)970611168 _z(OCoLC)972570632 _z(OCoLC)973139216 _z(OCoLC)974649973 _z(OCoLC)978505483 _z(OCoLC)1005820916
040			_aYDX _cYDX _dN$T _dGW5XE _dN$T _dAZU _dUAB _dOCLCQ _dOCLCF _dCOO _dUPM _dIOG _dMERER _dESU _dOCLCQ _dJBG _dIAD _dICW _dICN _dOTZ _dOCLCQ _dVT2 _dU3W _dES-MaUEC _bspa
050		4	_aRC280.P37 _b2017 EB
245	0	0	_aPenile cancer : _bdiagnosis and treatment _cPhilippe E. Spiess, editor.
250			_a2nd ed.
264		1	_aNew York, NY _bHumana Press _c2017
300			_a1 recurso en línea
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	0		_aCurrent clinical urology
505	0		_aUnderstanding the Pathophysiology of Penile Cancer and Its Preneoplastic Lesions -- Diagnostic Tools in the Evaluation and Management of Penile Cancer -- Penile-Sparing Surgical Approaches in the Management of Primary Penile Tumours -- Dynamic Sentinel Node Biopsy and FDG-PET/CT for Lymph Node Staging in Penile Cancer -- Surgical Decision Making, Technical Considerations and Clinical Pearls in Therapeutic Inguinal Node Dissection Surgery for Penile Cancer -- Minimally Invasive Surgical Approaches to Inguinal Nodes in the Absence of Palpable Adenopathy -- Pelvic Lymph Node Dissection for Penile Cancer: Answering the Conundrum of When and How It Should Be Conducted -- Multmodal Approach to Locally Advanced and Metastatic Penile Cancer -- The Role of Radiotherapy in the Management of Penile Cancer.
520	3		_aThis fully updated and revised second edition address specifically some of the significant advances made in our understanding of the pathophysiology of penile cancer including discussion of the suspected role of the human papilloma virus in penile carcinogenesis. Similarly, the molecular pathways implicated in precancerous and penile cancer will be discussed as these are the present targets of novel therapeutic approaches to this disease. The text details the recent national and international diagnostic and treatment guidelines that have been developed by both the National Comprehensive Cancer Network© and the European Urological Association establishing evidence based standards upon which the care of penile cancer should be based. The text also covers significant advances made in the diagnostic and therapeutic approach to both primary tumors and inguinal nodal metastases resulting from penile cancer such as penile sparing surgery and minimally invasive inguinal lymph node surgery. The text will similarly highlights the improvement in cancer specific outcome in the management of loco-regionally advanced (N2/3) penile cancer managed by upfront systemic chemotherapy followed by consolidative surgery in appropriately selected patients based on recent prospective phase II data. It also covers the role of radiotherapy in the management of penile cancer for both primary tumors and/or at sites of regional or distant metastases. Finally, some of the novel systemic approaches being devised in the management of advanced penile cancer along with some upcoming international trials soon to be opened which likely will re-define the present therapeutic approaches to penile cancer are discussed. The Second Edition of Penile Cancer: Diagnosis and Treatment will constitute a comprehensive review of the above mentioned subjects in addition to a few select topics of high clinical relevance, with the readership predominantly consisting of urologists, medical and surgical oncologists, and other healthcare professionals.
650		7	_aCáncer _xCirugía _2embne _0(OCoLC)fst00845532 _0 _9175031
700	1		_aSpiess, Philippe E., _d1972-
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-1-4939-6679-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988			_aSpringer_Medicine_2017
998			_b02/2018 _dz _e- _zSI
999			_c94941 _d94941 _x1